As many products implementing RNAi are under clinical trials and not approved till now, defining RNAi market is quite difficult. RNAi technologies market is broadly segmented by drug delivery, therapeutics & drug discovery, biomarker development & diagnostics and other research applications. Of these segments, drug discovery and therapeutics show tremendous potential as many drugs are in advanced stage of their clinical trials. Across therapeutics, RNAi is witnessing optimistic growth in neurological disorders, oncology and genetic disorders. Similarly, RNAi research tools & reagents market is also showing growth due to its application in therapeutics, diagnostics and agriculture sectors.
Drug delivery by electroporation, transfection or by injecting to tissues or blood vessels is expected to witness high growth and in turn will drive RNAi tools market. Other factors like target specificity and selectivity of RNAi therapeutics, increased interest by pharmaceutical companies for RNAi tools and virtual drug development are supporting the growth of RNAi based technologies. However, high costs associated with research, high failure rates and critical issues in drug delivery are posing challenges to the market.
ASDReport.com has good collection of reports on RNAi. The reports provide insights on various topics and applications related to RNAi like, RNA sequencing, small interfering RNA (SiRNA) therapeutics, miRNA, among others.